Notice NOT-TR-20-013 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-090 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-047 from the NIH Guide for Grants and Contracts

Notice NOT-ES-20-016 from the NIH Guide for Grants and Contracts

Notice NOT-TR-20-014 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-20-023 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications to continue the International epidemiology Databases to Evaluate AIDS (IeDEA) Program. The IeDEA program is comprised of 7 regional data center awards, which bring together clinical and research data within regions, and in collaboration monitor and guide the response to the HIV/AIDS epidemic. This research includes work on the long-term impact of HIV and its treatment, the epidemiology of common co-infections (e.g., hepatitis and tuberculosis). Research also evaluates health care utilization including medications, procedures, and vaccines, studies of co-morbidities such as cancer, disruption of physiological and metabolic processes leading to end organ impairment, mental health and alcohol and substance use. Data sources include clinical care, surveillance or research protocols as well as a Sentinel Research Network which collects data in a more intensive prospective cohort to understand the impact of non-communicable disease in HIV and allow for inferences across the network. This funding announcement also asks IeDEA to include a cohort of persons with tuberculosis (TB) to evaluate TB treatment outcomes. IeDEA facilitates access to data working with data consumers at the clinic, national, and global level and creating data tools.

Notice NOT-HL-20-780 from the NIH Guide for Grants and Contracts

Notice NOT-ES-20-015 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-759 from the NIH Guide for Grants and Contracts

Notice NOT-AI-20-041 from the NIH Guide for Grants and Contracts

Notice NOT-DA-20-046 from the NIH Guide for Grants and Contracts

Operationalize dispersed data through collecting, managing, and analyzing phenotypic data in preparation for further analysis.
From PepsiCo - Tue, 07 Apr 2020 08:03:51 GMT - View all Rhinelander, WI jobs

Funding Opportunity RFA-MD-20-008 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support multidisciplinary research examining mechanisms underlying racial and ethnic disparities in maternal mortality and morbidity and/or testing the efficacy and/or effectiveness of multi-level interventions to reduce these disparities.

Notice NOT-HD-20-008 from the NIH Guide for Grants and Contracts

Notice NOT-HS-20-010 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AR-21-002 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

Notice NOT-AI-20-042 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-20-525 from the NIH Guide for Grants and Contracts. The NIMH Biobehavioral Research Awards for Innovative New Scientists (BRAINS) award is intended to support the research and research career advancement of outstanding, exceptionally productive scientists who are in the early, formative stages of their careers and who plan to make a long-term career commitment to research in specific mission areas of the NIMH. This award seeks to assist these individuals in launching an innovative clinical, translational, basic, or services research program that holds the potential to profoundly transform the understanding, diagnosis, treatment, or prevention of mental disorders. The NIMH BRAINS program will focus on the research priorities and gap areas identified in the NIMH Strategic Plan.

Funding Opportunity RFA-AA-20-008 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) solicits research proposals to address significant challenges in Fetal Alcohol Spectrum Disorders (FASD) research in the areas of diagnosis/screening, etiology, interventions and treatment. Cooperative Agreement (UH2) applications in response to this FOA should propose exploratory/developmental projects, based on new and innovative concepts, approaches, and technologies. This solicitation is open to all. To maximize the impact of their research, awardees will be encouraged to establish a collaborative relationship with the NIAAA-supported Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) consortium.

Funding Opportunity RFA-AI-20-026 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to continue to provide operations support for Biosafety Level 4 (BSL4) facilities to the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs will serve as a national resource for efforts in conducting pre-clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAIDs biodefense and emerging infectious diseases research efforts. Additionally, in times of a national biodefense or emerging infectious disease (EID) emergency, the NBLs may be expected to rapidly realign their activities to assist response efforts within the US under the direction of NIAID.